Laura Wood on Multidisciplinary Collaboration for Managing Immunotherapy Adverse Events

Laura Wood on collaboration between departments when treating patients with cancer who are receiving immunotherapy treatments.

Laura Wood, RN, MSN, OCN, Cleveland Clinic explains the importance of a multidisciplinary approach when treating patients on immunotherapy.

Patients receiving immunotherapy treatments have autoimmune-type adverse events that are unlike those of chemotherapy. The side effects can be prolonged and require careful monitoring as well as multidisciplinary collaboration. Checking in with gastrointestinal, endocrinology, and other specialists can help to manage and monitor these side effects.

Related Videos
Arash Rezazadeh Kalebasty
Karyn Goodman
Reanne Booker on Factors to Consider When Discussing Palliative Radiation
Grace Choong
Mehra Details the Importance of PD-L1 Expression in HNSCC Treatment Selection
Related Content
© 2023 MJH Life Sciences

All rights reserved.